Welcure Drugs [WELCURE] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Welcure Drugs

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Welcure Drugs wins in 6 metrics, Innova Captab wins in 12 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWelcure DrugsInnova CaptabBetter
P/E Ratio (TTM)2.2437.44Welcure Drugs
Price-to-Book Ratio0.455.07Welcure Drugs
Debt-to-Equity Ratio120.1835.24Innova Captab
PEG Ratio0.007.14Welcure Drugs
EV/EBITDA5.5726.94Welcure Drugs
Profit Margin (TTM)7.96%9.98%Innova Captab
Operating Margin (TTM)10.38%11.68%Innova Captab
EBITDA Margin (TTM)10.38%11.68%Innova Captab
Return on Equity2.12%13.37%Innova Captab
Return on Assets (TTM)0.81%8.12%Innova Captab
Free Cash Flow (TTM)$-2.22B$-1.09BInnova Captab
1-Year Return-13.65%16.88%Innova Captab
Price-to-Sales Ratio (TTM)0.213.74Welcure Drugs
Enterprise Value$1.91B$51.37BInnova Captab
EV/Revenue Ratio0.593.95Welcure Drugs
Gross Profit Margin (TTM)10.40%37.21%Innova Captab
Revenue per Share (TTM)$38$227Innova Captab
Earnings per Share (Diluted)$2.69$22.70Innova Captab
Beta (Stock Volatility)-2.07N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Welcure Drugs vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Welcure Drugs
Innova Captab
Welcure Drugs Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Welcure Drugs4.97%20.73%-33.73%-43.59%-19.42%-40.13%
Innova Captab-0.80%-2.09%-4.29%-1.76%0.12%-24.72%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Welcure Drugs-13.65%-18.73%225.49%196.43%109.46%-49.31%
Innova Captab16.88%54.27%54.27%54.27%54.27%54.27%

News Based Sentiment: Welcure Drugs vs Innova Captab

Welcure Drugs

News based Sentiment: MIXED

October was a pivotal month for Welcure Drugs, marked by a potential acquisition offer and significant financial growth, but also continued stock volatility and regulatory scrutiny. The mixed signals create a complex investment picture, making it a significant month for the company's trajectory.

View Welcure Drugs News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported impressive revenue and profit growth for both Q1 FY2026 and the full fiscal year 2025-26, supported by a 'Buy' rating from JM Financial. While there were shifts in shareholding, particularly a decrease in FII holdings, the overall narrative points towards a positive trajectory for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Welcure Drugs vs Innova Captab

MetricWELCUREINNOVACAP
Market Information
Market Cap i₹712.18M₹48.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i8,204,99433,824
90 Day Avg. Volume i6,251,92640,665
Last Close₹6.97₹828.50
52 Week Range₹5.26 - ₹15.89₹662.00 - ₹1,260.00
% from 52W High-56.14%-34.25%
All-Time High₹25.00 (Sep 19, 2005)₹1,260.00 (Jan 06, 2025)
% from All-Time High-72.12%-34.25%
Growth Metrics
Quarterly Revenue Growth-34.93%0.20%
Quarterly Earnings GrowthN/A0.05%
Financial Health
Profit Margin (TTM) i0.08%0.10%
Operating Margin (TTM) i0.10%0.12%
Return on Equity (TTM) i0.02%0.13%
Debt to Equity (MRQ) i120.1835.24
Cash & Liquidity
Book Value per Share (MRQ)₹13.32₹167.66
Cash per Share (MRQ)₹0.01₹11.41
Operating Cash Flow (TTM) i₹-2,249,340,000₹282.88M
Levered Free Cash Flow (TTM) i₹21.70M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Welcure Drugs vs Innova Captab

MetricWELCUREINNOVACAP
Price Ratios
P/E Ratio (TTM) i2.2437.44
Forward P/E iN/A20.01
PEG Ratio i0.007.14
Price to Sales (TTM) i0.213.74
Price to Book (MRQ) i0.455.07
Market Capitalization
Market Capitalization i₹712.18M₹48.64B
Enterprise Value i₹1.91B₹51.37B
Enterprise Value Metrics
Enterprise to Revenue i0.593.95
Enterprise to EBITDA i5.5726.94
Risk & Other Metrics
Beta i-2.07N/A
Book Value per Share (MRQ) i₹13.32₹167.66

Financial Statements Comparison: Welcure Drugs vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WELCUREINNOVACAP
Revenue/Sales i₹3.00B₹3.52B
Cost of Goods Sold i₹2.69B₹2.21B
Gross Profit i₹311.96M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹311.36M₹410.54M
EBITDA i₹311.41M₹565.82M
Pre-Tax Income i₹311.36M₹426.77M
Income Tax i₹78.37M₹116.62M
Net Income (Profit) i₹232.99M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WELCUREINNOVACAP
Cash & Equivalents i₹1.28M₹155.19M
Total Current Assets i₹1.82B₹7.03B
Total Current Liabilities i₹412.69M₹3.53B
Long-Term Debt i₹1.23B₹2.45B
Total Shareholders Equity i₹1.03B₹9.59B
Retained Earnings i₹-100.79M₹4.53B
Property, Plant & Equipment iN/A₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WELCUREINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWELCUREINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i8,204,99433,824
Average Daily Volume (90 Day) i6,251,92640,665
Shares Outstanding i112.51M57.22M
Float Shares i14.84M15.70M
% Held by Insiders i0.85%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Welcure Drugs vs Innova Captab

MetricWELCUREINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A